GlassScriptPhysician profile
Ryan Anthony Baugher
NPI 1033595905
$2,026.40
in general payments reported to CMS, 2019-2025
37 companies · $896 in 2025
The $896 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $165 · 2021: $40.73 · 2022: $114 · 2023: $182 · 2024: $336 · 2025: $896.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,414.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $249.56 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $233.39 | 2019-2025 | |
| Pfizer INC. | $204.86 | 2019-2025 | |
| Amgen INC. | $196.43 | 2019-2025 | Evenity, Prolia, Otezla |
| Glaxosmithkline, LLC. | $98.86 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $84.80 | 2019-2025 | Jardiance, Emgality |
| Exact Sciences Corporation | $84.55 | 2024-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $83.52 | 2019-2025 | Airsupra |
| Teva Pharmaceuticals USA, INC. | $76.15 | 2019-2025 | Austedo Xr, Ajovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.93 | 2019-2024 | Jardiance |
| Boston Scientific Corporation | $57.44 | 2023 | Moses 550 D\F\L |
| Dexcom, INC. | $56.69 | 2023-2025 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $48.09 | 2025 | Veozah |
| Bioventus LLC | $32.40 | 2019 | |
| Stryker Corporation | $30.90 | 2025 | Mako |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Baugher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.